Sector Alpha Week of 2026-09-11
Not SEBI Registered !! Not Investment advice !!
Sector Alpha — machine-written from the numbers · Data as of 2026-09-11

LTM Ltd

LTM
IT - Software

LTM Ltd's earnings have outrun its stock. EPS grew +9.0% in a year against a −19.8% price move.

The sharpest disagreement: annual EPS moved +9.0% against a −19.8% price move — the market has not yet caught up with the delivery.

The price is in a downtrend (27 weeks in) while the P/E sits at the 36th percentile of its own 10-year range. Underneath, the last four quarters read improving — profit +17.1% year on year, and 106% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.

Stage
Consistent
fundamental trajectory, 12 quarters
Price
₹4,275
−19.8% 1Y
P/E
22.6×
36th pctile
of its own 10-year range
Revenue (Jun 26)
₹11,608 Cr
+18.0% YoY
Profit (Jun 26)
₹1,469 Cr
+17.1% YoY
Operating margin
18.0%
+1.0 pp YoY
ROCE
30%
FY26
ROIC
42.4%
vs WACC 12.0% → +30.4 pp
Cash conversion
106%
of profit, last 3 FY
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

LTM Ltd trades at ₹4,275, in a downtrend and 27 weeks into that stage. That is −7.4% against its own 200-day average. It sits at 26% of a 52-week range of ₹3,547 to ₹6,308. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 7 straight weeks.

Today the stock is in a downtrend — week 27 of stage 4, confirmed. At ₹4,275 it trades −7.4% versus its 200-day average and sits at 26% of its 52-week range (₹3,547–₹6,308).

Sep 26: ₹4,275 Weekly closing price (₹) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 3-year window.
−7.4% versus the 200-day line, week 27 of stage 4
Price50-day avg200-day avg
S2S4S2S4S2S4₹6,968₹6,049₹5,131₹4,212₹3,293₹4,275₹4,616Sep 23Jun 24Mar 25Jan 26Sep 26
S2S4S2S4S2S4₹6,968₹6,049₹5,131₹4,212₹3,293₹4,275₹4,616Sep 23Mar 25Sep 26
Beating or trailing, week by week since 2016 Each cell is one week from 2016 to now (536 weeks): the stock's trailing 13-week return minus the NIFTY 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the NIFTY 500 reading is not held.
trailing 13-week return vs the NIFTY 500
Jul 16Sep 26

Against the market, two honest reads. Cumulative: over the last 10.1 years the stock moved +511% while the NIFTY 500 moved +213% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 7 straight weeks — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.

LTM Ltd trades at 22.6× P/E, mid-range by its own standards (36th percentile). Its long-run median P/E is 26.9×, measured across 10.1 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 22.6× is mid-range by its own standards (36th percentile), against a long-run median of 26.9× measured over 10.1 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

P/E 22.6× vs a 26.9× long-run median P/E, weekly (left axis); earnings per share, trailing twelve months, weekly (right axis). 10.1-year window; loss-period spikes above 55× shown pinned at the top. The eps (ttm) bars are red where the reading is lower than the quarter before.
mid-range by its own standards (36th percentile)
P/EMedianEPS (TTM) (quarterly)
58.5×₹24345.8×₹18333.1×₹12220.4×₹60.87.7×₹0.0×22.60×₹189Jul 16Feb 19Sep 21Apr 24Sep 26
58.5×₹24345.8×₹18333.1×₹12220.4×₹60.87.7×₹0.0×22.60×₹189Jul 16Sep 21Sep 26
PEG 1.42 PEG ratio per quarter — the P/E divided by the earnings-growth rate. The dashed line marks 1.0: below it the growth is cheap against the multiple, above it the price already prices the growth in. Last 20 quarters.
above 1.0, the multiple already banks the growth
PEGPEG = 1.0
3.3×2.7×2.1×1.4×0.8××1.42×Q2 FY22Q2 FY23Q3 FY24Q4 FY25Q1 FY27
3.3×2.7×2.1×1.4×0.8××1.42×Q2 FY22Q3 FY24Q1 FY27
P/E
22.6×
36th percentile of 10y
PEG
1.61
as reported

Why the multiple sits where it does: over the past year annual EPS moved +9.0% against a −19.8% price move — earnings outran the price, pushing the multiple DOWN its own range.

The price move, decomposed: over 5y, of the −4.7%/yr price move, ~+10.4%/yr came from earnings growth and ~−15.1 pp from the multiple (compressing); over 10y, of the +20.9%/yr price move, ~+13.4%/yr came from earnings growth and ~+7.5 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.

Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.

03 · Stage: Consistent

Stage: Consistent Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

LTM Ltd reads as consistent on its fundamental arc. Consistent — revenue, profit and EPS growth have stayed positive through the window, with ROCE at 28.0% and holding. The read is built from 12 quarters across 4 curves, on full evidence.

Growth, year by year: revenue +11.3% in FY26, profit +8.3% Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn.
Revenue YoYProfit YoYEPS YoY
119%118%89%65%59%12%29%−41%−1.3%−94%%%11.3%8.3%FY16FY21FY26
119%118%89%65%59%12%29%−41%−1.3%−94%%%11.3%8.3%FY16FY21FY26
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. A missing point means that reading is not held for the quarter.
the trajectory the stage is read from · revenue accelerating, profit accelerating
RevenueProfitEPS
35%39%27%19%19%−2.0%11%−23%2.2%−43%%%13.9%10%10.7%Sep 23Dec 24Jun 26
35%39%27%19%19%−2.0%11%−23%2.2%−43%%%13.9%10%10.7%Sep 23Dec 24Jun 26
ROCE Trailing-twelve-month operating profit (before interest and tax) as a share of average capital employed — total assets minus current liabilities, the standard textbook basis, %.
the return curve, computed quarterly
ROCE
42%38%34%30%26%%28%Sep 23Mar 24Dec 24Sep 25Jun 26
42%38%34%30%26%%28%Sep 23Dec 24Jun 26
Revenue growth
Steady high
latest +13.9% · span +4.5% to +33.2%
Profit growth
Steady high
latest +10.0% · span −0.5% to +33.7%
EPS growth
Steady high
latest +10.7% · span −37.7% to +10.7%
ROCE
Steady high
latest 28.0% · span 27.1%–40.5%

Why it matters: steady curves with healthy returns are the compounding setup — the risk is the price, not the business.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; share price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+11.3%+8.4%+27.9%+21.9%
Profit+8.3%+4.2%+20.8%+19.5%
EPS+9.0%+4.3%+8.8%+13.1%
Share price−19.8%−7.9%−4.7%+20.9%
Revenue YoY (Jun 26)
+18.0%
latest quarter vs a year ago
Profit YoY (Jun 26)
+17.1%
latest quarter vs a year ago
Revenue 10y
21.9%
long-run compound pace
04 · 4-Factor Sector Score

4-Factor Sector Score

54.4/100 — rank 24 of 64 in IT - Software · 100% evidence confidence

LTM Ltd scores 54.4 out of 100 against the 64 companies it is compared with in IT - Software, ranking 24. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

The four contributions add to the total exactly: 17.1 + 17.9 + 10.7 + 8.7 = 54.4. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

LTM Ltd reported ₹11,608 Cr of revenue in the Jun 26 quarter, +18.0% year on year. That is the 12th straight quarter of year-on-year growth. Over 10 years it has compounded at 21.9% a year. The last full year, FY26, came in at ₹42,308 Cr. The last four reported quarters add to ₹44,075 Cr.

FY26 revenue came in at ₹42,308 Cr (+11.3% on the year), capping 10 years at 21.9% compound. The latest quarter (Jun 26) printed ₹11,608 Cr, +18.0% year on year — the 12th consecutive quarter of year-over-year growth.

FY26 revenue ₹42,308 Cr (+11.3% YoY) Revenue bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
21.9% a year over 10 years
RevenueYoY growth
45.7k119%34.3k89%22.8k59%11.4k29%0−1.3%₹ Cr%₹42,30811.3%FY16FY21FY26
45.7k119%34.3k89%22.8k59%11.4k29%0−1.3%₹ Cr%₹42,30811.3%FY16FY21FY26
Jun 26: ₹11,608 Cr (+18.0% YoY) Quarterly revenue bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
12th straight quarter of growth
Revenue (quarterly)YoY growth
12.5k91%9.4k67%6.3k43%3.1k19%0−4.2%₹ Cr%₹11,60818%Sep 23Dec 24Jun 26
12.5k91%9.4k67%6.3k43%3.1k19%0−4.2%₹ Cr%₹11,60818%Sep 23Dec 24Jun 26

Pace check: the last four quarters averaged +13.8% growth against the decade's 21.9% — the current year is running slower than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +13.9% over the last 4 quarters against +10.7%/yr over the last 8 — accelerating; TTM profit +10.0% vs +6.7%/yr — accelerating.

06 · Operating margin

Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

LTM Ltd's operating margin is 18.0% in the Jun 26 quarter, +1.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 16.0% to 23.0%. The current quarter sits inside that band.

The latest quarter's operating margin is 18.0%, +1.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 16.0%–23.0%.

Why the margin moved: operating margin went +1.0 pp year on year while gross margin went +0.0 pp — the gain came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.

FY26: 18.0% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 13-year window.
within a 16.0–23.0% band over 13 years
operating marginYoY change (pp)
24%4.6%22%2.5%20%0.5%17%−1.5%15%−3.6%%%18%1%FY14FY20FY26
24%4.6%22%2.5%20%0.5%17%−1.5%15%−3.6%%%18%1%FY14FY20FY26
Jun 26: 18.0% operating margin (+1.0 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
19.2%3.4%18.4%1.9%17.5%0.5%16.6%−0.9%15.8%−2.4%%%18%1%Sep 23Dec 24Jun 26
19.2%3.4%18.4%1.9%17.5%0.5%16.6%−0.9%15.8%−2.4%%%18%1%Sep 23Dec 24Jun 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

LTM Ltd earned ₹1,469 Cr of net profit in the Jun 26 quarter, +17.1% year on year. It is the 2nd consecutive quarter of growth. Full-year FY26 profit was ₹4,983 Cr. The 10-year compound rate is 19.5%. That is 12.7% of the quarter's revenue. The same quarter a year earlier earned ₹1,255 Cr.

Jun 26 profit was ₹1,469 Cr, +17.1% year on year — the 2nd consecutive quarter of growth. On the full year, FY26 printed ₹4,983 Cr (+8.3%), and the 10-year compound rate is 19.5%.

FY26 profit ₹4,983 Cr (+8.3% YoY) Net profit bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
19.5% a year over 10 years
Net profitYoY growth
5.4k112%4.0k82%2.7k52%1.3k22%0−8.0%₹ Cr%₹4,9838.3%FY16FY21FY26
5.4k112%4.0k82%2.7k52%1.3k22%0−8.0%₹ Cr%₹4,9838.3%FY16FY21FY26
Jun 26: ₹1,469 Cr (+17.1% YoY) Quarterly net profit bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
2nd straight quarter of growth
Net profit (quarterly)YoY growth
1.6k78%1.2k54%79330%3975.7%0−18%₹ Cr%₹1,46917.1%Sep 23Dec 24Jun 26
1.6k78%1.2k54%79330%3975.7%0−18%₹ Cr%₹1,46917.1%Sep 23Dec 24Jun 26

Why profit moved: revenue contributed +18.0% and the margin +1.0 pp — the quarter was revenue-led, with the margin roughly flat.

Pace comparison, last four quarters: profit +9.7% vs revenue +13.8%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.

08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 3 fiscal years 106% of LTM Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹4,799 Cr of operating cash against ₹4,983 Cr of profit. After ₹1,636 Cr of capital spending, ₹3,163 Cr was left as free cash.

FY26: operating cash of ₹4,799 Cr against reported profit of ₹4,983 Cr, leaving free cash of ₹3,163 Cr after ₹1,636 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 106% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY26: CFO ₹4,799 Cr vs profit ₹4,983 Cr Operating cash flow and net profit by fiscal year, ₹ Cr; the line is free cash flow (CFO minus capital spending). 11-year window, annual resolution.
106% of 3-year profit arrived as cash
Operating cashNet profitFree cash
6.1k4.6k3.1k1.5k0₹ Cr₹4,799₹4,983₹3,163FY16FY21FY26
6.1k4.6k3.1k1.5k0₹ Cr₹4,799₹4,983₹3,163FY16FY21FY26
FY26: CFO = 96% of profit (three-year rate 106%) Operating cash as a share of net profit, per fiscal year, % (line). Dashed line = 100% — every unit of profit arriving as cash.
Conversion100%
128%113%97%81%66%%96%FY16FY21FY26
128%113%97%81%66%%96%FY16FY21FY26

Why conversion sits at 106%: the cash cycle held roughly steady between FY21 and FY26 — so conversion tracks profitability rather than the cycle.

Router verdict: the bigger cash user is investment — capital spending ran 1.7× depreciation over three years, so the next section's job is to check what that build-out is buying.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

LTM Ltd's cash conversion cycle runs 64 days in FY26, up from 61 days in FY21. Capital spending ran ₹4,832 Cr over the last 3 years. At FY26 sales of ₹42,308 Cr each day of that cycle holds about ₹116 Cr, so roughly ₹7,418 Cr sits inside the business at any moment.

FY26: debtors at 64 days (an asset-light business — no inventory to speak of) — for a full cycle of 64 days, looser than FY21's 61.

In money terms: at FY26 sales of ₹42,308 Cr, each day of the cycle holds about ₹116 Cr — so the 64-day loop keeps roughly ₹7,418 Cr sitting inside the business at any moment.

FY26: a 64-day cash cycle Debtor days, inventory days, payable days and the cash conversion cycle by fiscal year. 13-year window.
+3 days vs FY21
Cash cycleDebtor days
8275686154days64d64dFY14FY17FY20FY23FY26
8275686154days64d64dFY14FY20FY26

On the investment side: capital spending of ₹4,832 Cr over the last 3 fiscal years against ₹2,865 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹922 Cr (FY26) — capacity paid for but not yet earning.

FY26: capex ₹1,636 Cr, work-in-progress ₹922 Cr Capital spending per fiscal year, ₹ Cr (bars); capital work-in-progress, ₹ Cr (line). Quarterly capital-spending history is not held for India — annual is the honest resolution.
a build-out
CapexWork-in-progress
2.8k2.1k1.4k7020₹ Cr₹1,636₹922FY16FY18FY21FY23FY26
2.8k2.1k1.4k7020₹ Cr₹1,636₹922FY16FY21FY26

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

10 · Return on capital

Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.

LTM Ltd earns a ROCE of 30% in FY26. That is up from a trough of 28% in FY25. Return on invested capital clears the cost of that capital by +30.4 percentage points, so growth here adds value rather than only size. The wiring behind it is 11.8% net margin on 1.14× asset turns.

FY26 ROCE is 30%, recovered from a FY25 trough of 28% — the full ladder below shows the fall and the climb, undoctored.

Why the return is what it is — the wiring (FY26): 11.8% net margin × 1.14× asset turns × 1.55× balance-sheet leverage ≈ 20.9% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.

The capstone test — ROIC − WACC: 42.4% − 12.0% = a +30.4 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. A spread this wide means every rupee reinvested creates more than a rupee of value — the engine compounds.

FY26: ROCE 30% Return on capital employed by fiscal year, % (line); ROIC by fiscal year, % (line). 13-year window, dips included. Dashed line = the 12.0% cost of capital used on this page.
the climb back from FY25's 28%
ROCEROIC (annual)WACC
80%62%44%25%7.0%%30%36.6%FY14FY20FY26
80%62%44%25%7.0%%30%36.6%FY14FY20FY26
Q1 FY27: ROCE 21.6% (TTM) vs WACC 12.0% Trailing-twelve-month ROCE and ROIC, per quarter, %; dashed line = the cost of capital. Last 12 quarters, put on a trailing-twelve-month basis and anchored to the annual figure.
ROCE (TTM)ROIC (TTM)WACC
43%35%27%18%9.7%%21.6%30.4%Q2 FY24Q3 FY25Q1 FY27
43%35%27%18%9.7%%21.6%30.4%Q2 FY24Q3 FY25Q1 FY27
11 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.

LTM Ltd carries total debt of ₹2,431 Cr against shareholder equity of ₹24,619 Cr as of Jun 26, a debt-to-equity of 0.10 — effectively unlevered. On the annual view that ratio went from 0.10 in FY22 to 0.10 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.

Jun 26: total debt of ₹2,431 Cr against shareholder equity of ₹24,619 Cr — a debt-to-equity of 0.10. On the annual view, debt-to-equity went from 0.10 (FY22) to 0.10 (FY26). The returns on this page are earned, not borrowed.

FY26: debt ₹2,310 Cr at 0.10× equity Total debt by fiscal year, ₹ Cr (bars); debt-to-equity, × (line). 5-year window.
Total debtDebt-to-equity
2.5k0.101×1.9k0.098×1.2k0.095×6240.092×00.089×₹ Cr×₹2,3100.10×FY22FY24FY26
2.5k0.101×1.9k0.098×1.2k0.095×6240.092×00.089×₹ Cr×₹2,3100.10×FY22FY24FY26
Jun 26: debt ₹2,431 Cr, debt-to-equity 0.10 Total debt per quarter, ₹ Cr (bars); debt-to-equity, × (line). Last 12 quarters. India reports the full balance sheet half-yearly, so the intervening quarter carries the prior reading forward.
Total debt (quarterly)Debt-to-equity
2.6k0.122×2.0k0.114×1.3k0.105×6560.096×00.088×₹ Cr×₹2,4310.10×Sep 23Dec 24Jun 26
2.6k0.122×2.0k0.114×1.3k0.105×6560.096×00.088×₹ Cr×₹2,4310.10×Sep 23Dec 24Jun 26
12 · Ownership

Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.

Domestic institutions added 2.6 points of LTM Ltd over 8 quarters, the biggest move on the register. That takes domestic institutions to 16.7% of the company. Foreign institutions moved −1.0 points over the same window, to 6.3%. The register is read on the four disclosed classes only; nothing is inferred between filings.

The register over the last two years — Domestic institutions: +2.6 points over 8 quarters to 16.7%; Foreign institutions: −1.0 points over 8 quarters to 6.3%; Promoters: −0.1 points over 8 quarters to 68.5%.

Why the register moved: domestic institutions drove it (+2.6 points), absorbed on the other side by foreign institutions (−1.0 points) — steady accumulation by institutions reading the same numbers this page reads.

Fiscal-year ends: promoters −0.1 pts from Mar 24 to Mar 26 Shareholding at each fiscal-year end (March quarter), % of the company. 3 year-ends held.
PromotersForeign inst.Domestic inst.Public
74%56%38%20%1.7%%68.5%6.6%16.9%7.8%Mar 24Mar 25Mar 26
74%56%38%20%1.7%%68.5%6.6%16.9%7.8%Mar 24Mar 25Mar 26
Domestic institutions added 2.6 points over 8 quarters Shareholding by holder class, % of the company, quarterly, last 13 quarters.
PromotersForeign inst.Domestic inst.Public
74%56%37%19%1.3%%68.5%6.3%16.7%8.3%Jun 23Dec 24Jun 26
74%56%37%19%1.3%%68.5%6.3%16.7%8.3%Jun 23Dec 24Jun 26
13 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

LTM Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.

The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.

14 · Related companies · IT - Software
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Coforge LtdCOFORGE 76.3/100Favorable setup100% evidence LEADER 30.0/35 Revenue 35.7% · PAT 66.5% · OPM change 3 pp 100% evidence 15.6/25 ROCE 23.5% · OPM 19% 100% evidence 12.3/20 P/E 42.7× · PEG 0.57 100% evidence 18.4/20 RS sector 13.3% · RS bench 20.1% · 1Y 11.3%12 of 12 weeks ahead 100% evidence
Exact sum: 30 + 15.6 + 12.3 + 18.4 = 76.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
2Silver Touch Technologies LtdSILVERTUC 70.0/100Favorable setup93% evidence FADING 30.2/35 Revenue 21.1% · PAT 86.4% · OPM change 8 pp 100% evidence 17.4/25 ROCE 29.8% · OPM 22% 100% evidence 10.3/20 P/E 46.4× · PEG 1.11 65% evidence 12.1/20 RS sector 6.1% · RS bench 14.1% · 1Y 120.3%9 of 12 weeks ahead 100% evidence
Exact sum: 30.2 + 17.4 + 10.3 + 12.1 = 70 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
3Sahana Systems LtdSAHANA 68.7/100Favorable setup70% evidence TURNING 21.5/35 Revenue 100% · PAT 100% · OPM change -3 pp 48% evidence 19.9/25 ROCE 39.8% · OPM 29% 95% evidence 13.4/20 P/E 14.1× · PEG — 50% evidence 13.9/20 RS sector -5.2% · RS bench 15.9% · 1Y -24.3%3 of 12 weeks ahead 100% evidence
Exact sum: 21.5 + 19.9 + 13.4 + 13.9 = 68.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
4ASM Technologies Ltd526433 68.2/100Favorable setup69% evidence BREAKING OUT 27.9/35 Revenue 67.8% · PAT 89.5% · OPM change 2 pp 95% evidence 16.1/25 ROCE 27% · OPM 23% 76% evidence 8.6/20 P/E 138× · PEG — 15% evidence 15.6/20 RS sector 5.7% · RS bench 97.1% · 1Y 94%10 of 10 weeks ahead 70% evidence
Exact sum: 27.9 + 16.1 + 8.6 + 15.6 = 68.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
5NINtec Systems LtdNINSYS 65.0/100Favorable setup80% evidence FADING 20.0/35 Revenue 21.6% · PAT 18.8% · OPM change 4.2 pp 95% evidence 21.9/25 ROCE 54% · OPM 25.9% 95% evidence 9.3/20 P/E 39.3× · PEG — 15% evidence 13.8/20 RS sector 29.6% · RS bench 37.6% · 1Y 57.1%9 of 12 weeks ahead 100% evidence
Exact sum: 20 + 21.9 + 9.3 + 13.8 = 65 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
6String Metaverse Ltd534535 63.4/100Mixed-positive evidence82% evidence BASING 27.2/35 Revenue 100% · PAT 100% · OPM change 0 pp 95% evidence 15.7/25 ROCE 41.6% · OPM 11% 76% evidence 14.8/20 P/E 8.2× · PEG — 50% evidence 5.7/20 RS sector -48% · RS bench -35.6% · 1Y -70.4%1 of 12 weeks ahead 100% evidence
Exact sum: 27.2 + 15.7 + 14.8 + 5.7 = 63.4 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -48% and the one-year return is -70.4%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
7Cigniti Technologies LtdCIGNITITEC 63.3/100Mixed-positive evidence73% evidence 23.4/35 Revenue 14% · PAT 96.1% · OPM change 2 pp 56% evidence 16.2/25 ROCE 34.1% · OPM 18% 75% evidence 16.2/20 P/E 11.4× · PEG 0.61 100% evidence 7.5/20 RS sector -10.2% · RS bench -15% · 1Y -19.7%0 of 12 weeks ahead to 2026-05-17 70% evidence
Exact sum: 23.4 + 16.2 + 16.2 + 7.5 = 63.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
8Tech Mahindra LtdTECHM 63.2/100Mixed-positive evidence94% evidence BREAKING OUT 21.1/35 Revenue 10.9% · PAT 14.3% · OPM change 3 pp 100% evidence 16.3/25 ROCE 23.1% · OPM 17% 100% evidence 10.6/20 P/E 28.4× · PEG 0.76 100% evidence 15.2/20 RS sector 14.8% · RS bench 4% · 1Y 4.3%8 of 11 weeks ahead 70% evidence
Exact sum: 21.1 + 16.3 + 10.6 + 15.2 = 63.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
9TAC Infosec LtdTAC 63.0/100Mixed-positive evidence66% evidence TURNING 25.6/35 Revenue 76.4% · PAT 59.4% · OPM change 1.6 pp 71% evidence 20.9/25 ROCE 38.1% · OPM 48.2% 95% evidence 9.5/20 P/E 35.7× · PEG — 15% evidence 7.0/20 RS sector -13.2% · RS bench -15.4% · 1Y -14.4%4 of 10 weeks ahead 70% evidence
Exact sum: 25.6 + 20.9 + 9.5 + 7 = 63 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
10Sasken Technologies LtdSASKEN 61.6/100Mixed-positive evidence100% evidence FADING 30.7/35 Revenue 67.8% · PAT 67.4% · OPM change 4 pp 100% evidence 8.1/25 ROCE 9.9% · OPM 9% 100% evidence 10.4/20 P/E 36.7× · PEG 0.68 100% evidence 12.4/20 RS sector 9.5% · RS bench 16.6% · 1Y 25%8 of 12 weeks ahead 100% evidence
Exact sum: 30.7 + 8.1 + 10.4 + 12.4 = 61.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
11Softtech Engineers LtdSOFTTECH 60.8/100Mixed-positive evidence80% evidence TURNING 25.2/35 Revenue 35.8% · PAT 100% · OPM change -0.1 pp 95% evidence 12.1/25 ROCE 6.2% · OPM 27.2% 95% evidence 8.7/20 P/E 124× · PEG — 15% evidence 14.8/20 RS sector 19.9% · RS bench 27.6% · 1Y 13.7%6 of 12 weeks ahead 100% evidence
Exact sum: 25.2 + 12.1 + 8.7 + 14.8 = 60.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
12Datamatics Global Services LtdDATAMATICS 60.7/100Mixed-positive evidence94% evidence ASLEEP 21.0/35 Revenue 13.1% · PAT 1.9% · OPM change 4 pp 100% evidence 15.9/25 ROCE 20.4% · OPM 20% 100% evidence 10.6/20 P/E 17.7× · PEG 0.69 100% evidence 13.2/20 RS sector 9.6% · RS bench -3.3% · 1Y -21.3%5 of 10 weeks ahead 70% evidence
Exact sum: 21 + 15.9 + 10.6 + 13.2 = 60.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
13IZMO LtdIZMO 60.6/100Mixed-positive evidence81% evidence FADING 24.1/35 Revenue 24.7% · PAT 10.2% · OPM change 8 pp 95% evidence 14.2/25 ROCE 12.6% · OPM 25% 95% evidence 6.6/20 P/E 25.3× · PEG — 50% evidence 15.7/20 RS sector 29% · RS bench 7.6% · 1Y 20.9%8 of 10 weeks ahead 70% evidence
Exact sum: 24.1 + 14.2 + 6.6 + 15.7 = 60.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
14Danlaw Technologies India Ltd532329 59.9/100Mixed-positive evidence67% evidence TURNING 21.8/35 Revenue 24.1% · PAT 34.5% · OPM change 0.8 pp 95% evidence 15.5/25 ROCE 27.6% · OPM 13.4% 76% evidence 10.2/20 P/E 32× · PEG — 50% evidence 12.4/20 RS sector — · RS bench 93% · 1Y —4 of 4 weeks ahead 25% evidence
Exact sum: 21.8 + 15.5 + 10.2 + 12.4 = 59.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
15Expleo Solutions LtdEXPLEOSOL 59.6/100Mixed-positive evidence81% evidence TURNING 20.9/35 Revenue 10.4% · PAT 39.4% · OPM change 4 pp 95% evidence 15.8/25 ROCE 24.2% · OPM 15% 95% evidence 13.7/20 P/E 9.4× · PEG — 50% evidence 9.2/20 RS sector -13.3% · RS bench 1.4% · 1Y -12.8%2 of 10 weeks ahead 70% evidence
Exact sum: 20.9 + 15.8 + 13.7 + 9.2 = 59.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
16Hypersoft Technologies Ltd539724 59.6/100Mixed-positive evidence67% evidence FADING 25.5/35 Revenue 100% · PAT 100% · OPM change 2.9 pp 71% evidence 11.9/25 ROCE 20.6% · OPM 14% 76% evidence 8.6/20 P/E 386× · PEG — 15% evidence 13.6/20 RS sector 40.8% · RS bench 50.5% · 1Y 116.6%10 of 12 weeks ahead 100% evidence
Exact sum: 25.5 + 11.9 + 8.6 + 13.6 = 59.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
17InfoBeans Technologies LtdINFOBEAN 58.9/100Mixed-positive evidence87% evidence ASLEEP 26.5/35 Revenue 35.5% · PAT 60.4% · OPM change 0 pp 95% evidence 16.9/25 ROCE 29.2% · OPM 21% 95% evidence 9.7/20 P/E 17.6× · PEG — 50% evidence 5.8/20 RS sector -12.9% · RS bench -6.5% · 1Y 10.4%3 of 12 weeks ahead 100% evidence
Exact sum: 26.5 + 16.9 + 9.7 + 5.8 = 58.9 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -12.9% and the one-year return is 10.4%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
18R Systems International LtdRSYSTEMS 57.5/100Mixed-positive evidence100% evidence BASING 18.9/35 Revenue 24.1% · PAT -1% · OPM change 3 pp 100% evidence 16.5/25 ROCE 19.5% · OPM 18% 100% evidence 17.7/20 P/E 13.5× · PEG 0.26 100% evidence 4.4/20 RS sector -28.2% · RS bench -23.7% · 1Y -46.9%0 of 12 weeks ahead 100% evidence
Exact sum: 18.9 + 16.5 + 17.7 + 4.4 = 57.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
19Ksolves India LtdKSOLVES 57.3/100Mixed-positive evidence87% evidence ASLEEP 17.8/35 Revenue 16% · PAT 16.7% · OPM change 3.9 pp 95% evidence 20.7/25 ROCE 131% · OPM 30.3% 95% evidence 13.8/20 P/E 16.5× · PEG — 50% evidence 5.0/20 RS sector -16.6% · RS bench -10.9% · 1Y -19.3%0 of 12 weeks ahead 100% evidence
Exact sum: 17.8 + 20.7 + 13.8 + 5 = 57.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
20BLS E-Services LtdBLSE 56.8/100Mixed-positive evidence75% evidence LEADER 18.1/35 Revenue 71.2% · PAT 9.4% · OPM change 0 pp 95% evidence 10.3/25 ROCE 16.4% · OPM 7% 76% evidence 9.0/20 P/E 48.9× · PEG — 15% evidence 19.4/20 RS sector 41.8% · RS bench 50.4% · 1Y 75.9%12 of 12 weeks ahead 100% evidence
Exact sum: 18.1 + 10.3 + 9 + 19.4 = 56.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
21Subex LtdSUBEXLTD 56.5/100Mixed-positive evidence65% evidence BREAKING OUT 24.4/35 Revenue 2.8% · PAT 100% · OPM change 13 pp 95% evidence 10.3/25 ROCE 12.8% · OPM 19% 95% evidence 9.4/20 P/E 36.2× · PEG — 15% evidence 12.4/20 RS sector — · RS bench 80.4% · 1Y —9 of 9 weeks ahead 25% evidence
Exact sum: 24.4 + 10.3 + 9.4 + 12.4 = 56.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
22Saksoft LtdSAKSOFT 55.7/100Mixed-positive evidence100% evidence BREAKING OUT 17.9/35 Revenue 8.2% · PAT 13% · OPM change 0 pp 100% evidence 15.6/25 ROCE 25.5% · OPM 18% 100% evidence 13.5/20 P/E 14.5× · PEG 0.6 100% evidence 8.7/20 RS sector -16% · RS bench -10.8% · 1Y -30.5%12 of 12 weeks ahead 100% evidence
Exact sum: 17.9 + 15.6 + 13.5 + 8.7 = 55.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
23Infosys LtdINFY 55.1/100Mixed-positive evidence82% evidence ASLEEP 18.1/35 Revenue 11.2% · PAT 11.1% · OPM change 0 pp 95% evidence 20.1/25 ROCE 40% · OPM 24% 76% evidence 14.0/20 P/E 13.5× · PEG — 50% evidence 2.9/20 RS sector -26.2% · RS bench -21.2% · 1Y -28.2%0 of 12 weeks ahead 100% evidence
Exact sum: 18.1 + 20.1 + 14 + 2.9 = 55.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
24LTM Ltdthis pageLTM 54.4/100Mixed-positive evidence100% evidence BREAKING OUT 17.1/35 Revenue 13.9% · PAT 10% · OPM change 1 pp 100% evidence 17.9/25 ROCE 29.6% · OPM 18% 100% evidence 10.7/20 P/E 22.6× · PEG 1.18 100% evidence 8.7/20 RS sector -17.1% · RS bench -11.7% · 1Y -17.7%5 of 12 weeks ahead 100% evidence
Exact sum: 17.1 + 17.9 + 10.7 + 8.7 = 54.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
25AvenuesAI LtdCCAVENUE 53.6/100Mixed-positive evidence93% evidence BREAKING OUT 20.9/35 Revenue 100% · PAT 43.8% · OPM change -2.3 pp 100% evidence 5.0/25 ROCE 7.7% · OPM 3.7% 100% evidence 14.8/20 P/E 19.2× · PEG 0.37 65% evidence 12.9/20 RS sector -4.7% · RS bench 1.7% · 1Y 0.7%12 of 12 weeks ahead 100% evidence
Exact sum: 20.9 + 5 + 14.8 + 12.9 = 53.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
26Xchanging Solutions LtdXCHANGING 53.6/100Mixed-positive evidence81% evidence TURNING 18.6/35 Revenue 8.4% · PAT 13.2% · OPM change 1 pp 95% evidence 15.5/25 ROCE 18% · OPM 34% 95% evidence 13.6/20 P/E 11.4× · PEG — 50% evidence 5.9/20 RS sector -24.4% · RS bench -11.2% · 1Y -30.2%1 of 10 weeks ahead 70% evidence
Exact sum: 18.6 + 15.5 + 13.6 + 5.9 = 53.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
27Blue Cloud Softech Solutions LtdBLUECLOUDS 53.0/100Mixed-positive evidence74% evidence 22.0/35 Revenue 41.1% · PAT 36.2% · OPM change 10 pp 95% evidence 12.4/25 ROCE 14.2% · OPM 20% 95% evidence 9.6/20 P/E 27.6× · PEG — 15% evidence 9.0/20 RS sector -3.8% · RS bench -8.7% · 1Y -33.2%1 of 12 weeks ahead 70% evidence
Exact sum: 22 + 12.4 + 9.6 + 9 = 53 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
28TechNVision Ventures LtdTECHNVISN 52.9/100Mixed-positive evidence74% evidence ASLEEP 25.9/35 Revenue 23.4% · PAT 100% · OPM change 2.9 pp 95% evidence 5.5/25 ROCE 12.9% · OPM 5.2% 95% evidence 8.5/20 P/E 1002× · PEG — 15% evidence 13.0/20 RS sector 32.1% · RS bench -14% · 1Y -20.6%0 of 9 weeks ahead 70% evidence
Exact sum: 25.9 + 5.5 + 8.5 + 13 = 52.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
29Seshaasai Technologies LtdSTYL 52.3/100Mixed-positive evidence73% evidence BREAKING OUT 12.6/35 Revenue 6.7% · PAT 20.6% · OPM change 0 pp 100% evidence 17.1/25 ROCE 27.7% · OPM 23% 100% evidence 12.6/20 P/E 23.7× · PEG 0.81 65% evidence 10.0/20 RS sector — · RS bench — · 1Y -9.1%10 of 10 weeks ahead 0% evidence
Exact sum: 12.6 + 17.1 + 12.6 + 10 = 52.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
30Tanla Platforms LtdTANLA 52.2/100Mixed-positive evidence94% evidence ASLEEP 14.4/35 Revenue 13.2% · PAT 9.9% · OPM change 0 pp 100% evidence 16.5/25 ROCE 26.3% · OPM 16% 100% evidence 13.1/20 P/E 12.5× · PEG 1.21 100% evidence 8.2/20 RS sector -12% · RS bench -5.7% · 1Y -23.7%6 of 10 weeks ahead 70% evidence
Exact sum: 14.4 + 16.5 + 13.1 + 8.2 = 52.2 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
31Tata Consultancy Services LtdTCS 50.6/100Mixed-positive evidence100% evidence TURNING 10.0/35 Revenue 7.7% · PAT 1.1% · OPM change -1 pp 100% evidence 22.5/25 ROCE 63% · OPM 26% 100% evidence 11.9/20 P/E 14.8× · PEG 1.85 100% evidence 6.2/20 RS sector -21.5% · RS bench -16.2% · 1Y -27.8%0 of 12 weeks ahead 100% evidence
Exact sum: 10 + 22.5 + 11.9 + 6.2 = 50.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
32Capillary Technologies India LtdCAPILLARY 50.4/100Mixed-positive evidence63% evidence ASLEEP 27.4/35 Revenue 27.8% · PAT 135.8% · OPM change 5.8 pp 100% evidence 4.1/25 ROCE 3.4% · OPM 15.7% 100% evidence 8.9/20 P/E 71.8× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y —0 of 10 weeks ahead 0% evidence
Exact sum: 27.4 + 4.1 + 8.9 + 10 = 50.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
33RNIT AI Solutions LtdAUTOPALIND 50.4/100Thin evidence · provisional55% evidence BREAKING OUT 16.9/35 Revenue 56.7% · PAT 71.3% · OPM change -0.6 pp 95% evidence 14.6/25 ROCE 20.2% · OPM 35.3% 76% evidence 8.9/20 P/E 68× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y —5 of 12 weeks ahead 0% evidence
Exact sum: 16.9 + 14.6 + 8.9 + 10 = 50.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
34Birlasoft LtdBSOFT 50.3/100Mixed-positive evidence100% evidence ASLEEP 19.7/35 Revenue 1.4% · PAT 21.1% · OPM change 4 pp 100% evidence 13.0/25 ROCE 21.2% · OPM 16% 100% evidence 14.6/20 P/E 13.2× · PEG 0.62 100% evidence 3.0/20 RS sector -26% · RS bench -20.6% · 1Y -25%0 of 12 weeks ahead 100% evidence
Exact sum: 19.7 + 13 + 14.6 + 3 = 50.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
35Mphasis LtdMPHASIS 49.0/100Mixed-negative evidence94% evidence FADING 15.0/35 Revenue 13.7% · PAT 9.9% · OPM change -1 pp 100% evidence 17.3/25 ROCE 22.1% · OPM 18% 100% evidence 6.0/20 P/E 22.6× · PEG 2.19 100% evidence 10.7/20 RS sector 0% · RS bench -7% · 1Y -18%3 of 10 weeks ahead 70% evidence
Exact sum: 15 + 17.3 + 6 + 10.7 = 49 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression.
36Hexaware Technologies LtdHEXT 48.9/100Mixed-negative evidence94% evidence FADING 14.2/35 Revenue 13% · PAT 1.2% · OPM change 4 pp 100% evidence 17.8/25 ROCE 30.1% · OPM 16% 100% evidence 10.7/20 P/E 21.4× · PEG 0.81 100% evidence 6.2/20 RS sector -21.4% · RS bench -14.7% · 1Y -31.1%6 of 10 weeks ahead 70% evidence
Exact sum: 14.2 + 17.8 + 10.7 + 6.2 = 48.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
37HCL Technologies LtdHCLTECH 48.2/100Mixed-negative evidence82% evidence BREAKING OUT 12.2/35 Revenue 12.6% · PAT 2.6% · OPM change 0 pp 95% evidence 19.0/25 ROCE 30.4% · OPM 20% 76% evidence 9.0/20 P/E 18× · PEG — 50% evidence 8.0/20 RS sector -18.3% · RS bench -12.7% · 1Y -15%7 of 12 weeks ahead 100% evidence
Exact sum: 12.2 + 19 + 9 + 8 = 48.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
38Mastek LtdMASTEK 47.9/100Mixed-negative evidence82% evidence FADING 13.8/35 Revenue 6% · PAT 5% · OPM change 0 pp 95% evidence 13.3/25 ROCE 17.7% · OPM 15% 76% evidence 12.6/20 P/E 11.5× · PEG — 50% evidence 8.2/20 RS sector -16.4% · RS bench -11.1% · 1Y -33.2%4 of 12 weeks ahead 100% evidence
Exact sum: 13.8 + 13.3 + 12.6 + 8.2 = 47.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
39Dynacons Systems & Solutions LtdDSSL 47.2/100Mixed-negative evidence87% evidence ASLEEP 16.8/35 Revenue 10.5% · PAT 16.2% · OPM change 3 pp 95% evidence 15.4/25 ROCE 29.8% · OPM 13% 95% evidence 8.1/20 P/E 15.9× · PEG — 50% evidence 6.9/20 RS sector -7% · RS bench -0.5% · 1Y 9%6 of 12 weeks ahead 100% evidence
Exact sum: 16.8 + 15.4 + 8.1 + 6.9 = 47.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
40Zensar Technologies LtdZENSARTECH 46.6/100Mixed-negative evidence100% evidence ASLEEP 15.6/35 Revenue 8% · PAT 15.3% · OPM change 0 pp 100% evidence 13.6/25 ROCE 22.8% · OPM 15% 100% evidence 14.3/20 P/E 12.2× · PEG 1.11 100% evidence 3.1/20 RS sector -33% · RS bench -28.6% · 1Y -45.2%0 of 12 weeks ahead 100% evidence
Exact sum: 15.6 + 13.6 + 14.3 + 3.1 = 46.6 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
41Unicommerce eSolutions LtdUNIECOM 46.6/100Mixed-negative evidence74% evidence ASLEEP 14.4/35 Revenue 38.4% · PAT 18.1% · OPM change -8.1 pp 95% evidence 16.5/25 ROCE 21.1% · OPM 10.6% 95% evidence 9.1/20 P/E 44.1× · PEG — 15% evidence 6.6/20 RS sector -14.5% · RS bench -19.2% · 1Y -44.1%0 of 10 weeks ahead 70% evidence
Exact sum: 14.4 + 16.5 + 9.1 + 6.6 = 46.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
42XT Global Infotech LtdXTGLOBAL 46.5/100Mixed-negative evidence61% evidence 18.4/35 Revenue 85.4% · PAT 29.4% · OPM change -6.6 pp 53% evidence 9.4/25 ROCE 7.5% · OPM 9.5% 71% evidence 9.1/20 P/E 40.8× · PEG — 50% evidence 9.6/20 RS sector -1% · RS bench -12.7% · 1Y -21.9%2 of 12 weeks ahead to 2026-03-29 70% evidence
Exact sum: 18.4 + 9.4 + 9.1 + 9.6 = 46.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
43Wipro LtdWIPRO 45.0/100Mixed-negative evidence100% evidence BASING 12.9/35 Revenue 6.4% · PAT -1.7% · OPM change 0 pp 100% evidence 15.3/25 ROCE 17.8% · OPM 19% 100% evidence 13.5/20 P/E 12.5× · PEG 1.4 100% evidence 3.3/20 RS sector -25.8% · RS bench -20.8% · 1Y -31.3%0 of 12 weeks ahead 100% evidence
Exact sum: 12.9 + 15.3 + 13.5 + 3.3 = 45 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
44Excelsoft Technologies LtdEXCELSOFT 44.3/100Mixed-negative evidence60% evidence TURNING 12.0/35 Revenue 26.8% · PAT 4.2% · OPM change -1.8 pp 95% evidence 12.2/25 ROCE 13.6% · OPM 16.3% 95% evidence 10.1/20 P/E 18.7× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y —0 of 10 weeks ahead 0% evidence
Exact sum: 12 + 12.2 + 10.1 + 10 = 44.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
45Sonata Software LtdSONATSOFTW 43.1/100Mixed-negative evidence100% evidence BREAKING OUT 9.0/35 Revenue 4% · PAT 7.9% · OPM change 0 pp 100% evidence 13.6/25 ROCE 30.7% · OPM 5% 100% evidence 13.1/20 P/E 14.7× · PEG 0.81 100% evidence 7.4/20 RS sector -17.3% · RS bench -12.1% · 1Y -25.9%11 of 12 weeks ahead 100% evidence
Exact sum: 9 + 13.6 + 13.1 + 7.4 = 43.1 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
4663 Moons Technologies Ltd63MOONS 43.1/100Thin evidence · provisional58% evidence BREAKING OUT 20.6/35 Revenue 100% · PAT -80% · OPM change 128 pp 71% evidence 3.4/25 ROCE -3.7% · OPM -52% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 9.1/20 RS sector -22.4% · RS bench 28.9% · 1Y -1.6%10 of 11 weeks ahead 70% evidence
Exact sum: 20.6 + 3.4 + 10 + 9.1 = 43.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
47Magellanic Cloud LtdMCLOUD 38.9/100Mixed-negative evidence81% evidence TURNING 9.6/35 Revenue 13.7% · PAT 6.7% · OPM change -7 pp 95% evidence 13.9/25 ROCE 19.8% · OPM 28% 95% evidence 11.9/20 P/E 13.6× · PEG — 50% evidence 3.5/20 RS sector -54.4% · RS bench -23.4% · 1Y -68%6 of 11 weeks ahead 70% evidence
Exact sum: 9.6 + 13.9 + 11.9 + 3.5 = 38.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
48Innovana Thinklabs LtdINNOVANA 38.7/100Mixed-negative evidence81% evidence TURNING 8.7/35 Revenue 26% · PAT -39% · OPM change -32.5 pp 95% evidence 11.3/25 ROCE 15.8% · OPM 17.6% 95% evidence 9.0/20 P/E 21.9× · PEG — 50% evidence 9.7/20 RS sector -0.4% · RS bench -15.1% · 1Y -40.3%0 of 10 weeks ahead 70% evidence
Exact sum: 8.7 + 11.3 + 9 + 9.7 = 38.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
49Kellton Tech Solutions LtdKELLTONTEC 36.2/100Mixed-negative evidence87% evidence BASING 10.0/35 Revenue 9.5% · PAT 9.6% · OPM change -1 pp 95% evidence 9.7/25 ROCE 15% · OPM 11% 95% evidence 11.9/20 P/E 8× · PEG — 50% evidence 4.6/20 RS sector -24.3% · RS bench -19.4% · 1Y -45.5%0 of 12 weeks ahead 100% evidence
Exact sum: 10 + 9.7 + 11.9 + 4.6 = 36.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
50Aurionpro Solutions LtdAURIONPRO 36.1/100Mixed-negative evidence93% evidence ASLEEP 12.9/35 Revenue 14.8% · PAT 5.1% · OPM change -3 pp 100% evidence 10.7/25 ROCE 16.3% · OPM 17% 100% evidence 10.0/20 P/E 18× · PEG 1.39 65% evidence 2.5/20 RS sector -30.2% · RS bench -25.6% · 1Y -47.2%2 of 12 weeks ahead 100% evidence
Exact sum: 12.9 + 10.7 + 10 + 2.5 = 36.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
51Allied Digital Services LtdADSL 35.5/100Mixed-negative evidence74% evidence BASING 14.2/35 Revenue 19.1% · PAT 5.6% · OPM change 0 pp 95% evidence 6.5/25 ROCE 7.4% · OPM 9% 95% evidence 10.7/20 P/E 14.6× · PEG — 15% evidence 4.1/20 RS sector -29.8% · RS bench -24.4% · 1Y -39.4%1 of 10 weeks ahead 70% evidence
Exact sum: 14.2 + 6.5 + 10.7 + 4.1 = 35.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
52Mindteck (India) LtdMINDTECK 32.3/100Adverse evidence87% evidence ASLEEP 7.9/35 Revenue -1.8% · PAT 0.3% · OPM change -1.7 pp 95% evidence 10.4/25 ROCE 15.1% · OPM 7.8% 95% evidence 11.8/20 P/E 15.3× · PEG — 50% evidence 2.2/20 RS sector -27.9% · RS bench -23.1% · 1Y -24.6%3 of 12 weeks ahead 100% evidence
Exact sum: 7.9 + 10.4 + 11.8 + 2.2 = 32.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
53Moschip Technologies LtdMOSCHIP 31.1/100Adverse evidence87% evidence TURNING 7.7/35 Revenue 8.4% · PAT -33.6% · OPM change -3.9 pp 100% evidence 7.0/25 ROCE 11% · OPM 8.2% 100% evidence 3.7/20 P/E 129× · PEG 5.04 65% evidence 12.7/20 RS sector 1.9% · RS bench 0.9% · 1Y -15.1%3 of 10 weeks ahead 70% evidence
Exact sum: 7.7 + 7 + 3.7 + 12.7 = 31.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
54Orient Technologies LtdORIENTTECH 30.7/100Thin evidence · provisional54% evidence BASING 15.1/35 Revenue — · PAT — · OPM change -0.5 pp 19% evidence 2.4/25 ROCE 8.4% · OPM 6.7% 95% evidence 9.0/20 P/E 45.6× · PEG — 15% evidence 4.2/20 RS sector -21.8% · RS bench -16.7% · 1Y -9.4%0 of 12 weeks ahead 100% evidence
Exact sum: 15.1 + 2.4 + 9 + 4.2 = 30.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
55Quick Heal Technologies LtdQUICKHEAL 20.4/100Adverse evidence69% evidence BASING 6.2/35 Revenue -6.6% · PAT -80% · OPM change -22.1 pp 71% evidence 1.8/25 ROCE -6% · OPM -39% 95% evidence 10.0/20 P/E — · PEG — 0% evidence 2.4/20 RS sector -32.9% · RS bench -29.1% · 1Y -50.2%2 of 12 weeks ahead 100% evidence
Exact sum: 6.2 + 1.8 + 10 + 2.4 = 20.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
56Covance Softsol Ltd544361 66.8/100Thin evidence · provisional49% evidence 25.8/35 Revenue 43.5% · PAT 100% · OPM change 19.7 pp 62% evidence 17.8/25 ROCE 31.4% · OPM 23.1% 76% evidence 11.1/20 P/E 12.9× · PEG — 15% evidence 12.1/20 RS sector — · RS bench 48.4% · 1Y — 25% evidence
Exact sum: 25.8 + 17.8 + 11.1 + 12.1 = 66.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
57Exato Technologies Ltd544626 57.8/100Thin evidence · provisional38% evidence TURNING 21.0/35 Revenue — · PAT — · OPM change 3.4 pp 45% evidence 17.5/25 ROCE 26.8% · OPM 18% 76% evidence 9.3/20 P/E 40× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y —4 of 4 weeks ahead 0% evidence
Exact sum: 21 + 17.5 + 9.3 + 10 = 57.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
58Unified Data- Tech Solutions LtdUNIFIED 56.1/100Thin evidence · provisional36% evidence 16.9/35 Revenue — · PAT — · OPM change 1 pp 26% evidence 18.8/25 ROCE 45.2% · OPM 15% 76% evidence 10.2/20 P/E 18.6× · PEG — 15% evidence 10.2/20 RS sector — · RS bench -1.2% · 1Y 15.3%0 of 12 weeks ahead 25% evidence
Exact sum: 16.9 + 18.8 + 10.2 + 10.2 = 56.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
59Kody Technolab LtdKODYTECH 54.2/100Thin evidence · provisional48% evidence BREAKING OUT 15.2/35 Revenue — · PAT — · OPM change -5 pp 19% evidence 14.4/25 ROCE 16.8% · OPM 29% 95% evidence 8.7/20 P/E 125× · PEG — 15% evidence 15.9/20 RS sector 10.3% · RS bench 61.9% · 1Y 107.4%10 of 10 weeks ahead 70% evidence
Exact sum: 15.2 + 14.4 + 8.7 + 15.9 = 54.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
60Metalic Technoforge LtdMETA 53.0/100Thin evidence · provisional27% evidence 16.2/35 Revenue — · PAT — · OPM change -2 pp 13% evidence 17.1/25 ROCE 36.1% · OPM 8% 76% evidence 9.7/20 P/E 25.3× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y -12.7%0 of 12 weeks ahead 0% evidence
Exact sum: 16.2 + 17.1 + 9.7 + 10 = 53 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
61Veefin Solutions LtdVEEFIN 47.3/100Thin evidence · provisional50% evidence 17.7/35 Revenue — · PAT — · OPM change -5.1 pp 19% evidence 10.6/25 ROCE 9.8% · OPM 19.7% 76% evidence 12.2/20 P/E 27.7× · PEG — 50% evidence 6.8/20 RS sector -7.2% · RS bench -24.9% · 1Y -40%0 of 12 weeks ahead 70% evidence
Exact sum: 17.7 + 10.6 + 12.2 + 6.8 = 47.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
62Trident Techlabs LtdTECHLABS 45.8/100Thin evidence · provisional40% evidence 16.0/35 Revenue — · PAT — · OPM change -2 pp 15% evidence 16.2/25 ROCE 26.7% · OPM 27% 71% evidence 10.5/20 P/E 14.9× · PEG — 15% evidence 3.1/20 RS sector -50.2% · RS bench -56.5% · 1Y -72.5%0 of 12 weeks ahead to 2026-03-29 70% evidence
Exact sum: 16 + 16.2 + 10.5 + 3.1 = 45.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
63ERP Soft Systems Ltd530909 44.2/100Thin evidence · provisional41% evidence 19.8/35 Revenue 19.1% · PAT 100% · OPM change -1.1 pp 53% evidence 8.0/25 ROCE 1.6% · OPM 1.7% 57% evidence 8.8/20 P/E 74.9× · PEG — 15% evidence 7.6/20 RS sector — · RS bench -47.6% · 1Y -59.7%0 of 12 weeks ahead to 2026-03-29 25% evidence
Exact sum: 19.8 + 8 + 8.8 + 7.6 = 44.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
64IDream Film Infrastructure Company Ltd504375 38.2/100Thin evidence · provisional35% evidence TURNING 12.8/35 Revenue — · PAT 100% · OPM change — 33% evidence 3.1/25 ROCE -9.2% · OPM -25.8% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 12.3/20 RS sector — · RS bench 78% · 1Y —8 of 8 weeks ahead 25% evidence
Exact sum: 12.8 + 3.1 + 10 + 12.3 = 38.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

15 · Frequently asked questions

Frequently asked questions

What is LTM Ltd's share price today?

LTM Ltd trades at ₹4,275, −19.8% over the past year. The company is valued at ₹1,26,806 Cr. The stock sits at 26% of its 52-week range of ₹3,547–₹6,308, −7.4% versus its 200-day average. On the tape, the price is in a downtrend, 27 weeks in. — as of 11 September 2026.

What were LTM Ltd's latest quarterly results?

LTM Ltd reported revenue of ₹11,608 Cr and net profit of ₹1,469 Cr for the Jun 26 quarter. Revenue rose 18.0% and profit rose 17.1% year on year. Earnings per share were ₹49.43. The operating margin was 18.0%, 1.0 pp higher than a year earlier. — as of 11 September 2026.

What is LTM Ltd's revenue?

LTM Ltd reported revenue of ₹11,608 Cr in the Jun 26 quarter, +18.0% year on year. For the full FY26 fiscal year, revenue was ₹42,308 Cr (+11.3%). Over the last 10 years revenue compounded at 21.9% a year. — as of 11 September 2026.

What is LTM Ltd's profit?

LTM Ltd earned ₹1,469 Cr of net profit in the Jun 26 quarter, +17.1% year on year — the 2nd straight quarter of growth. Full-year FY26 profit was ₹4,983 Cr. The operating margin ran 18.0% in the latest quarter. — as of 11 September 2026.

What is LTM Ltd's market cap?

LTM Ltd's market capitalisation is ₹1,26,806 Cr at a share price of ₹4,275. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.

What is LTM Ltd's P/E ratio?

LTM Ltd trades at a P/E of 22.6×, at the 36th percentile of its own 10-year range, against a long-run median of 26.9×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.

Does LTM Ltd pay a dividend?

Yes — LTM Ltd's dividend payout was 44% of profit in FY26, and it recorded a payout in each of its last 13 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 11 September 2026.

Is LTM Ltd overvalued?

On its own history, LTM Ltd looks mid-range: its P/E of 22.6× sits at the 36th percentile of its 10-year range (long-run median 26.9×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 11 September 2026.

Is LTM Ltd growing?

Yes — LTM Ltd is growing: latest-quarter revenue +18.0% year on year, profit +17.1%, and the margin +1.0 pp at 18.0%. The 10-year compound rates are 21.9% (revenue) and 19.5% (profit). The earnings engine currently reads: improving — as of 11 September 2026.

How is LTM Ltd performing?

LTM Ltd is in a downtrend, 27 weeks in. Its latest quarter's revenue rose 18.0% and profit rose 17.1% year on year. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 7 weeks. This describes what the data did, not a rating. — as of 11 September 2026.

What stage is LTM Ltd in?

Consistent — revenue, profit and EPS growth have stayed positive through the window, with ROCE at 28.0% and holding. The read comes from the last 12 quarters of growth (revenue growth +13.9% latest, profit growth +10.0% latest, eps growth +10.7% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 11 September 2026.

Is LTM Ltd in an uptrend?

No — the price is in a downtrend (week 27 of stage 4), trading −7.4% versus its 200-day average and at 26% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.

Is LTM Ltd beating the market?

On recent form, yes — LTM Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 7 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.1 years the stock moved +511% against the NIFTY 500's +213% — ahead of the index over the full window. — as of 11 September 2026.

Will LTM Ltd's share price go up?

This page publishes no price forecast for LTM Ltd. What it measures instead: the share price is ₹4,275, the price is in a downtrend 27 weeks in. Its P/E of 22.6× sits at the 36th percentile of its own 10-year range. Direction is not something this site claims to know. — as of 11 September 2026.

Who owns LTM Ltd?

Promoters hold 68.5% of LTM Ltd, foreign institutions 6.3%, domestic institutions 16.7% and the public 8.3% (latest quarter). The biggest move on the register over the last two years: Domestic institutions added 2.6 points over 8 quarters. — as of 11 September 2026.

Does LTM Ltd have too much debt?

No — LTM Ltd's debt-to-equity is 0.10, and operating profit covers the interest bill 27×. FY26 borrowings were ₹2,310 Cr against equity of ₹24,025 Cr. The returns on this page are earned, not borrowed — as of 11 September 2026.

What is LTM Ltd's capex?

LTM Ltd spent ₹4,832 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹1,636 Cr, with ₹922 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 11 September 2026.

What is LTM Ltd's cash flow?

LTM Ltd generated ₹4,799 Cr of operating cash flow in FY26 and ₹3,163 Cr of free cash flow after ₹1,636 Cr of capital spending. Reported profit that year was ₹4,983 Cr, so operating cash ran behind profit. Cash-flow resolution for India is annual. — as of 11 September 2026.

Is LTM Ltd's profit real cash?

Yes — over the last 3 fiscal years, 106% of LTM Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹4,799 Cr against reported profit of ₹4,983 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 11 September 2026.

Where is LTM Ltd in its business cycle?

LTM Ltd's FY26 operating margin was 18.0%, against a 13-year band of 16.0%–23.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 18.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.

What could break the LTM Ltd story?

The sharpest disagreement: annual EPS moved +9.0% against a −19.8% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.

Is LTM Ltd a stock worth studying right now?

This is not investment advice. The machine read: LTM Ltd's earnings have outrun its stock. EPS grew +9.0% in a year against a −19.8% price move. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.

Sector Alpha — machine-written from the numbers · Data as of 2026-09-11. Every chart on this page is drawn by deterministic code from the raw series — no forecasts, no price opinions, and nothing here is investment advice.

Not SEBI Registered !! Not Investment advice !!

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI